The most commonly reported side effects of tyropanoate include gastric cancer, based on 1 FDA adverse event reports from 2006 to 2006.
Percentages show how often each reaction appears relative to total reports for tyropanoate.
These are voluntary reports and do not establish that tyropanoate caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside tyropanoate. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Taken alongside
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
Conditions and purposes for which patients were taking tyropanoate when the adverse event was reported.
Tyropanoate is sold under the brand name Bilopaque.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.